Losartan to Improve Hip Microfracture

NCT04212650 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped redesigned trial using another placebo controlled drug

Conditions

Hip Osteoarthritis
Hip Impingement Syndrome
Cartilage Damage
Fibrosis

Interventions

DRUG: Losartan
OTHER: Placebo

Sponsor

Steadman Philippon Research Institute

Collaborators

[object Object]
[object Object]